BCLI - BrainStorm submits SPA request to FDA for Phase 3 study design February, 23 2024 01:24 PM Brainstorm Cell Therapeutics Inc. 2024-02-23 13:24:46 ET More on BrainStorm Cell Therapeutics BrainStorm Cell Therapeutics spikes on patent wins Seeking Alpha’s Quant Rating on BrainStorm Cell Therapeutics Historical earnings data for BrainStorm Cell Therapeutics Financial information for BrainStorm Cell Therapeutics For further details see: BrainStorm submits SPA request to FDA for Phase 3 study design